US Food and Drug Administration Shifts to AI-Enhanced Regulatory Review With Elsa 4.0 and HALO
Unlabelled: The US Food and Drug Administration recently announced the launch of Elsa 4.0 and Harmonized AI and Lifecycle Operations for Data (HALO)-an upgrade to its artificial intelligence platform. In this News and Perspectives article, JMIR Correspondent Tejas S Athni reports on the evolution of the Elsa model and potential benefits and challenges.
Authors
- Tejas S. Athni (ORCID: https://orcid.org/0000-0002-6336-0826)
Publication Details
- Journal
- Journal of Medical Internet Research
- Published
- 2026-05-29
- DOI
- https://doi.org/10.2196/101884
- Primary Topic
- Artificial Intelligence in Healthcare and Education
- Type
- article
- Field-Weighted Citation Impact
- 0.00